Frank Ruffo
Net Worth

Last updated:

What is Frank Ruffo net worth?

The estimated net worth of Mr. Frank Ruffo is at least $9,983,247 as of 10 Mar 2022. He owns shares worth $353,295 as insider, has earned $4,398,522 from insider trading and has received compensation worth at least $5,231,430 in Aclaris Therapeutics, Inc..

What is the salary of Frank Ruffo?

Mr. Frank Ruffo salary is $581,270 per year as Co-Founder, Chief Financial Officer & Treasurer in Aclaris Therapeutics, Inc..

How old is Frank Ruffo?

Mr. Frank Ruffo is 59 years old, born in 1966.

What stocks does Frank Ruffo currently own?

As insider, Mr. Frank Ruffo owns shares in one company:

Company Title Shares Price per share Total value
Aclaris Therapeutics, Inc. (ACRS) Co-Founder, Chief Financial Officer & Treasurer 201,883 $1.75 $353,295

What does Aclaris Therapeutics, Inc. do?

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

ACRS logo
ACRS
Aclaris Therapeutics, Inc.
$1.75

Frank Ruffo insider trading

Aclaris Therapeutics, Inc.

Mr. Frank Ruffo has made 9 insider trades between 2016-2022, according to the Form 4 filled with the SEC. Most recently he sold 12,823 units of ACRS stock worth $199,334 on 10 Mar 2022.

The largest trade he's ever made was exercising 33,189 units of ACRS stock on 1 Jun 2021. As of 10 Mar 2022 he still owns at least 201,883 units of ACRS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 12,823 $15.55 $199,334
Option
Restricted stock units 8,297 N/A N/A
Option
Restricted stock units 8,300 N/A N/A
Option
Common Stock 8,297 N/A N/A
Option
Restricted stock units 25,750 N/A N/A
Option
Common Stock 8,300 N/A N/A
Option
Common Stock 25,750 N/A N/A
Sale
Common Stock 1,388 $12.66 $17,568
Option
Common Stock 3,875 N/A N/A
Option
Restricted Stock Units 3,875 N/A N/A
Sale
Common Stock 15,037 $21.91 $329,385
Sale
Common Stock 15,037 N/A N/A
Option
Common Stock 33,189 N/A N/A
Option
Restricted Stock Units 33,189 N/A N/A
Sale
Common Stock 27,339 $26.12 $714,013
Sale
Common Stock 27,339 $26.12 $714,013
Sale
Common Stock 30,000 $26.98 $809,490
Sale
Common Stock 30,000 $26.98 $809,490
Sale
Common Stock 30,000 $26.84 $805,230
Option
Restricted stock units 8,297 N/A N/A
Option
Common Stock 8,297 N/A N/A
Option
Common Stock 25,750 N/A N/A
Option
Restricted stock units 25,750 N/A N/A
Option
Common Stock 3,875 N/A N/A
Option
Restricted Stock Units 3,875 N/A N/A
Option
Common Stock 1,300 N/A N/A
Option
Restricted Stock Units 1,300 N/A N/A
Option
Common Stock 33,188 N/A N/A
Option
Restricted stock units 33,188 N/A N/A
Option
Restricted stock units 25,750 $1.26 $32,445
Option
Common Stock 25,750 $1.26 $32,445
Option
Restricted Stock Units 3,875 N/A N/A
Option
Common Stock 3,875 N/A N/A
Option
Common Stock 1,250 N/A N/A
Option
Restricted Stock Units 1,250 N/A N/A
Option
Restricted Stock Units 1,300 N/A N/A
Option
Common Stock 1,300 N/A N/A
Option
Restricted Stock Units 3,875 N/A N/A
Option
Common Stock 3,875 N/A N/A
Option
Common Stock 1,250 N/A N/A
Option
Restricted Stock Units 1,250 N/A N/A
Option
Common Stock 1,300 N/A N/A
Option
Restricted Stock Units 1,300 N/A N/A
Purchase
Common Stock 1,250 $18.22 $22,775
Option
Common Stock 5,200 N/A N/A
Option
Restricted Stock Units 5,200 N/A N/A
Purchase
Common Stock 1,250 $16.59 $20,738
Option
Common Stock 1,250 N/A N/A
Option
Restricted Stock Units 1,250 N/A N/A
Option
Restricted Stock Units 1,300 N/A N/A
Option
Common Stock 1,300 N/A N/A
Option
Common Stock 1,250 N/A N/A
Option
Restricted Stock Units 1,250 N/A N/A

Aclaris Therapeutics key executives

Aclaris Therapeutics, Inc. executives and other stock owners filed with the SEC: